Abstract: The present invention is concerned with solid oral dosage forms of comprising
a) an active agent selected from valsartan and optionally HCTZ , and
b) Pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
Type:
Grant
Filed:
August 1, 2001
Date of Patent:
November 26, 2002
Assignee:
Novartis AG
Inventors:
Robert Frank Wagner, Yoshimitsu Katakuse, Takashi Taike, Fujiki Yamato, Manfred Kohlmeyer